Cargando…

Net present value approaches for drug discovery

Three dedicated approaches to the calculation of the risk-adjusted net present value (rNPV) in drug discovery projects under different assumptions are suggested. The probability of finding a candidate drug suitable for clinical development and the time to the initiation of the clinical development i...

Descripción completa

Detalles Bibliográficos
Autores principales: Svennebring, Andreas M, Wikberg, Jarl ES
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing AG 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622797/
https://www.ncbi.nlm.nih.gov/pubmed/23586005
http://dx.doi.org/10.1186/2193-1801-2-140

Ejemplares similares